Tag:Cannavigia

Transparency For Cannabis Pilot Trials In Switzerland

PRESS RELEASE FOR the first time, cannabis is being sold legally in Switzerland. On 30 January, selected participants of the Weed Care study within the...

What’s In Store For The European Cannabis Industry In 2023? (Part 2)

You can read Part 1 of our 2023 predictions here. Enexis AB According to the cannabis investment firm Enexis, economic pressures will mean capital available...

Vigia AG Signs MoU With Teera Botanicals Co. Ltd

PRESS RELEASE Vigia AG joins hands with Teera Botanicals Co., Ltd to support the research and compliance of cannabis cultivation in Thailand according to GACP...

Europe’s First Recreational THC Cannabis Trial Will ‘Open The Door For THC’ In Switzerland Like ‘CBD Opened The Door For Cannabis’

SWITZERLAND is just weeks away from launching Europe’s ‘first recreational THC cannabis pilot project’, the first in what is thought to be nearly a...

Switzerland Has ‘Laid The Groundwork For Its Medical Cannabis Industry To Flourish’ And Could Soon Be Exporting ‘Very High-Quality Flower’

LAST week Switzerland became the latest in a string of European countries to relax its restrictive access to medical cannabis for both patients and...

‘Through Full Transparency’ Modern Technology Can Make A Lot Of Today’s Regulatory Standards Obsolete

THE confluence of hundreds of cannabis industry professionals from over 30 countries at this year's Cannabis Europa London saw a recurring talking point emerge,...

Latest news

European Cannabis Stocks Review: Celadon Shares Spike 150% On Licence Update, OCT Continues Recovery, & Creso Pharma Censured By ASX

Celadon Pharmaceuticals  Celadon Pharmaceuticals stock has skyrocketed by more than 150% this week following the announcement that its current Home...
- Advertisement -spot_imgspot_img

Benefits of F1 Cannabis Hybrids from Royal Queen Seeds

F1 hybrids have revolutionised the way we grow and use plants. Now, F1 cannabis seeds are bringing growers, smokers,...

Celadon Pharmaceuticals Announces Home Office Approval Of Licence For Commercial Sale Of GMP Cannabis

PRESS RELEASE FURTHER to the announcement dated 16 January 2023, Celadon Pharmaceuticals Plc (AIM: CEL), a UK-based pharmaceutical company focused on...

Must read